Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market
Information
Our
common stock has been quoted through various over-the-counter quotation systems at various times since 2009. Our common stock currently
trades on the OTCQB Markets under the symbol “RNGE.”
The
following table sets forth the range of reported high and low closing bid quotations for our common stock for the fiscal quarters indicated
as reported by OTCQB Markets Group. Common stock price reflects inter-dealer quotations, does not include retail markups, markdowns or
commissions and does not necessarily represent actual transactions.
High
Low
Fiscal Year Ended December 31, 2023
First Quarter ended March 31, 2023
$ 0.20
$ 0.15
Second Quarter ended June 30, 2023
0.20
0.15
Third Quarter ended September 30, 2023
0.20
0.10
Fourth Quarter ended December 31, 2023
0.37
0.12
Fiscal Year Ended December 31, 2024
First Quarter ended March 31, 2024
$ 0.41
$ 0.37
Second Quarter ended June 30, 2024
0.37
0.36
Third Quarter ended September 30, 2024
0.32
0.26
Fourth Quarter ended December 31, 2024
0.21
0.18
Transfer
Agent
The
transfer agent and registrar for our common stock is Securities Transfer Corporation, 2901 North Dallas Parkway, Suite 380, Plano, Texas
75093.
Holders
of Common Stock
As
of March 28, 2025, there were 72 holders of record of our common stock.
Dividends
We
have never declared or paid any cash dividends or distributions on our common stock. We currently intend to retain our future earnings,
if any, to support operations and to finance expansion, and we do not anticipate paying any cash dividends on our common stock in the
foreseeable future.
Equity
Compensation Plan Information
During
the year ended December 31, 2024, we issued options to purchase 250,000 shares of the Company’s common stock under the Range Impact,
Inc. 2021 Stock Incentive Plan. Except as listed in the table below, as of December 31, 2024, we do not have any equity-based plans,
including individual compensation arrangements, which have not been approved by our stockholders.
24
The
following table provides information as of December 31, 2024 with respect to our equity compensation plans:
Equity
Compensation Plan Information
Plan Category
Number
of
securities
to be
issued
upon
exercise
of
outstanding
options,
warrants
and
rights
Weighted-
average
exercise
price
of
outstanding
options,
warrants
and
rights
Number
of
securities
remaining
available
for
future
issuance
under
equity
compensation
plans
(excluding
securities
reflected
in
column
(a))
(a)
(b)
(c)
Equity compensation
plans approved by security holders
11,594,210
$ 0.45
3,900,000
Total
11,594,210
$ 0.45
3,900,000
Item
6. Selected Financial Data
[Reserved].